This software, in development thanks to funding from Prostate Cancer UK, aims to analyze blood samples from thousands of patients to detect genetic mutations associated with the most aggressive forms of the disease.
Professor Ros Eeles from the Institute of Cancer Research explains that the objective is to create a model capable of predicting, from a simple blood sample, whether prostate cancer will be aggressive.
“This would allow clinicians to target intensive treatments to patients most at risk from the earliest stages of the disease, thereby changing the way cancer is managed,” she emphasizes.
Each year, around 59,000 men are diagnosed with prostate cancer in France, with one in eight men experiencing it during their lifetime. Although most cases progress slowly, some patients develop aggressive forms which can be fatal within a few years, causing around 10,000 deaths annually. The current challenge for doctors is to distinguish, at the time of diagnosis, patients who will develop a severe form from those who will be able to live with the disease for years without symptoms or treatment.
Professor Eeles and his team plan to tester…
Read more
Health
